Cerus (CERS) SEC Filings: History & Chart

Cerus Corporation(CERS)

Medical - Devices · Concord, CA

$2.29-0.05 (-2.14%)

Delayed quote: Oct 6, 2026, 10:20 AM EDT

About Cerus Corporation

Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEPT Blood System. This proprietary technology significantly enhances the safety of transfusable blood components by neutralizing biological threats, thereby reducing the risk of blood-borne pathogens. The company's product line includes INTERCEPT systems specifically engineered to deactivate pathogens in donated platelets and plasma. It also offers a dedicated INTERCEPT Blood System for the inactivation of harmful agents in red blood cell components. Furthermore, Cerus markets an INTERCEPT Blood System for Cryoprecipitation, which leverages its plasma technology to produce two key pathogen-reduced blood products: a cryoprecipitated fibrinogen complex for treating and controlling bleeding, particularly massive hemorrhages stemming from fibrinogen deficiency, and pathogen-reduced, cryoprecipitate-reduced plasma. Cerus distributes these platelet and plasma systems globally through a combination of its direct sales force and an extensive network of distributors, reaching markets in North America, Europe, the Commonwealth of Independent States, the Middle East, and Latin America. Established in 1991, Cerus Corporation maintains its corporate headquarters in Concord, California.

Concord, CA

268 employees

www.cerus.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Vivek K. Jayaraman

View full financials

Form	Filing Date	Accepted	Document
4	Aug 17, 2026	Aug 17, 2026	View filing
SC 13G/A	Aug 14, 2026	Aug 14, 2026	View filing
SC 13G/A	Aug 14, 2026	Aug 14, 2026	View filing
SC 13G/A	Aug 13, 2026	Aug 13, 2026	View filing
S-8	Jul 30, 2026	Jul 30, 2026	View filing
10-Q	Jul 30, 2026	Jul 30, 2026	View filing
8-K	Jul 30, 2026	Jul 30, 2026	View filing
4	Jul 20, 2026	Jul 20, 2026	View filing
8-K	Jul 10, 2026	Jul 10, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jun 11, 2026	Jun 11, 2026	View filing
8-K	Jun 8, 2026	Jun 8, 2026	View filing
4	Jun 2, 2026	Jun 2, 2026	View filing
4	Jun 2, 2026	Jun 2, 2026	View filing
4	Jun 2, 2026	Jun 2, 2026	View filing
4	Jun 2, 2026	Jun 2, 2026	View filing
4	Jun 2, 2026	Jun 2, 2026	View filing
4	Jun 2, 2026	Jun 2, 2026	View filing
4	Jun 2, 2026	Jun 2, 2026	View filing
SD	May 29, 2026	May 29, 2026	View filing
4	May 5, 2026	May 5, 2026	View filing
10-Q	Apr 30, 2026	Apr 30, 2026	View filing
8-K	Apr 30, 2026	Apr 30, 2026	View filing
ARS	Apr 22, 2026	Apr 22, 2026	View filing
DEFA14A	Apr 22, 2026	Apr 22, 2026	View filing
DEF 14A	Apr 22, 2026	Apr 22, 2026	View filing
8-K	Apr 21, 2026	Apr 21, 2026	View filing

SEC Filings

Recent Filings